Segev DL - Search Results

1

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo.

Segev DL, Hoshiya Y, Stephen AE, Hoshiya M, Tran TT, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. J Biol Chem. 2001 Jul 20;276(29):26799-806. doi: 10.1074/jbc.M103092200. Epub 2001 May 16. J Biol Chem. 2001. PMID: 11356848 Free article.

2

Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.

Segev DL, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. J Biol Chem. 2000 Sep 15;275(37):28371-9. doi: 10.1074/jbc.M004554200. J Biol Chem. 2000. PMID: 10874041 Free article.

3

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism.

Ha TU, Segev DL, Barbie D, Masiakos PT, Tran TT, Dombkowski D, Glander M, Clarke TR, Lorenzo HK, Donahoe PK, Maheswaran S. Ha TU, et al. Among authors: segev dl. J Biol Chem. 2000 Nov 24;275(47):37101-9. doi: 10.1074/jbc.M005701200. J Biol Chem. 2000. PMID: 10958795 Free article.

4

Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

Stephen AE, Masiakos PT, Segev DL, Vacanti JP, Donahoe PK, MacLaughlin DT. Stephen AE, et al. Among authors: segev dl. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3214-9. doi: 10.1073/pnas.051625998. Epub 2001 Feb 27. Proc Natl Acad Sci U S A. 2001. PMID: 11248058 Free PMC article.

5

Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.

Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S. Segev DL, et al. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):239-44. doi: 10.1073/pnas.221599298. Epub 2002 Jan 2. Proc Natl Acad Sci U S A. 2002. PMID: 11773638 Free PMC article.

6

The diagnosis of acute appendicitis in a pediatric population: to CT or not to CT.

Stephen AE, Segev DL, Ryan DP, Mullins ME, Kim SH, Schnitzer JJ, Doody DP. Stephen AE, et al. Among authors: segev dl. J Pediatr Surg. 2003 Mar;38(3):367-71; discsussion 367-71. doi: 10.1053/jpsu.2003.50110. J Pediatr Surg. 2003. PMID: 12632351 Review.

7

Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells.

Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, Sasur LM, Tran TT, Ha TU, Maheswaran S. Hoshiya Y, et al. Among authors: segev dl. Mol Cell Endocrinol. 2003 Dec 15;211(1-2):43-9. doi: 10.1016/j.mce.2003.09.010. Mol Cell Endocrinol. 2003. PMID: 14656475

8

Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism.

Tran TT, Segev DL, Gupta V, Kawakubo H, Yeo G, Donahoe PK, Maheswaran S. Tran TT, et al. Among authors: segev dl. Mol Endocrinol. 2006 Oct;20(10):2382-91. doi: 10.1210/me.2005-0480. Epub 2006 Jun 1. Mol Endocrinol. 2006. PMID: 16740653

9

Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.

McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. McKee M, et al. J Pediatr Surg. 1997 May;32(5):688-90. doi: 10.1016/s0022-3468(97)90006-3. J Pediatr Surg. 1997. PMID: 9165452 Free article. Clinical Trial.

10

Living unrelated renal transplantation: a good match for the pediatric candidate?

Van Arendonk KJ, Orandi BJ, James NT, Segev DL, Colombani PM. Van Arendonk KJ, et al. Among authors: segev dl. J Pediatr Surg. 2013 Jun;48(6):1277-82. doi: 10.1016/j.jpedsurg.2013.03.023. J Pediatr Surg. 2013. PMID: 23845618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

920 results

Search Page

Filters